Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging
Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute
Hoffmann-La Roche
Boehringer Ingelheim
Hebei Medical University Fourth Hospital
National Cancer Institute (NCI)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Nagoya City University
ALX Oncology Inc.
Dana-Farber Cancer Institute
Hoosier Cancer Research Network
Fudan University
Seagen Inc.
Fate Therapeutics
DualityBio Inc.
Criterium, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Hoffmann-La Roche
Shanghai Jiao Tong University School of Medicine
University of Nebraska
Institut Paoli-Calmettes